Health Care Sciences

Lab Faculty Member(s) Room
Human Performance Lab Moh Malek 1228
Instructional Technology Lab

Fredrick D. Pociask and Rosanne DiZazzo-Miller


Neuroimaging and Neurorehabilitation Lab (NNL)

Both motor (e.g., walking, strength, balance) and cognitive (e.g. thinking, memory, attention) factors interact to influence rehabilitation outcomes. The overarching goal of our lab is to develop novel rehabilitation strategies to target motor and cognitive decline in individuals with neurodegenerative diseases, including multiple sclerosis and Huntington's disease.

Nora Fritz  

Neuromuscular Regenerative Rehabilitation Research Group (NR3G)

Improving or optimizing muscle function in all individuals. Researchers are engaged in several studies aimed at gaining a better understanding of why individuals with certain neuromuscular diseases show greater levels of exercise-induced muscle injury. With the knowledge gained from these studies, they hope to develop novel rehabilitative, pharmacological, gene- and cell-based therapies that could improve resistance to muscle injury in individuals with neuromuscular diseases as well as in healthy individuals.

Joseph A. Roche 4440
Neurotechnology Lab Sujay Galen and Victoria Pardo 1210

Pharmaceutical Sciences

Lab Faculty Member(s) Room

Chen Lab

Investigating genetic and epigenetic effectives of extracellular inducers, including ROS and cytokines, on the development and progression of human lung and other cancers caused by exposure to varied agents, including mineral dust and carcinogenic metals

Fei Chen 3520

Commissaris Lab

Seeking to further understanding of the neuroanatomical sites and neuropharmacological mechanisms for the actions of drugs and other chemicals on behavior.

Randall Commissaris 5465

Corcoran Lab

Studying cellular injury and cell death as well as factors governing drug and chemical-induced injuries, including drug metabolism and nutrition.

George Corcoran 3520
Driving Simulator Lab Randall Commissaris 1215

Dutta Group

Investigating the mechanism of action of novel CNS active molecules and advancing promising leads to preclinical studies.

Aloke K. Dutta 4340

Firestine Lab

Exploring the discovery and elucidation of anti-infective agents.

Steve Firestine 3330

Hirata Lab

Examining translocation and modifications of annexin A1 in nuclei to explore its role in carcinogenesis and cell transformation.

Fusao Hirata 3440

Iyer Lab

Developing use-inspired nano-medical technologies aimed towards clinical translation using biocompatible delivery systems that have enhanced disease targeting with reduced toxicity burden to patients.

Arun Iyer 5320

Kowluru Lab

Working to identify specific genes that must be regulated by glucose to induce insulin secretion, to determine novel drug targets to rectify these defects, and to develop beta cells resistant to immune attack for use in transplantation of Type 1 diabetes

Anjan Kowluru 3437

Moszczynska Lab

Explores methamphetamine neurotoxicity and the role of ubiquitin E3 ligases in neuronal damage.

Anna Moszczynska 3437
Pitts Lab David Pitts 3430
Proteomics Lab Zhengping Yi 0250
Qin Lab Zhihui Qin 3341

Stemmler Lab

Obtaining a molecular/atomic level characterization of the structure and function of biomolecules involved in cellular metal homeostasis pathways.

Timothy Stemmler 3250

Yi Lab

Developing of a better understanding of the basic biology of insulin signaling and the etiology of insulin resistance.

Zhengping Yi 3330

Pharmacy Practice

Lab Faculty Member(s) Room

Anti-Infective Research Laboratory

Investigating antimicrobial pharmacokinetics, dynamics and resistance.

Michael J. Rybak 4341
Pharmacognenomics Lab Kyle Burghardt 4340
Translational Neuropsychopharmacology Lab Christine Davie 0215/0221